DNA Synthesis Market Analysis

By Service (Oligonucleotide Synthesis, Gene Synthesis)

The oligonucleotide synthesis segment is anticipated to account for DNA synthesis market share of around 56.5% by 2037. The segment is further classified into standard oligonucleotide synthesis and custom oligonucleotide synthesis. The ongoing advancements in oligonucleotide synthesis are anticipated to boost their applications in genomic sequencing, molecular diagnosis, and synthetic biology. Also, the rise in research activities in the above-mentioned fields augments a high demand for custom-synthesized oligonucleotides. Universities, research institutes, and biotech labs widely rely on these oligonucleotides due to their high precision and accuracy.

By Application (Research & Development, Diagnostics, Therapeutics)

The oligonucleotide synthesis segment is anticipated to account for DNA synthesis market share of around 56.5% by 2037. The research and development activities help to improve the DNA synthesis techniques and explore new application areas. The increasing investments by end use organizations such as biotechnology and pharmaceutical, universities, and market players to enhance and expand their research and development capabilities are contributing to the segmental growth.

DNA synthesis technology manufacturers are also raising funds to strengthen their R&D facilities and operations. For instance, in April 2023, NunaBio a TechBio producer of synthetic DNA for chemical research announced that it raised USD 2.5 million in seed funding to expand and accelerate its R&D infrastructure and activities. The funding was supported by the European Regional Development Fund and managed by Northstar Ventures, Pioneer Group, Ascension Life Fund, and Martlet Capital.

Our in-depth analysis of the DNA synthesis market includes the following segments: